BioMed X and Servier launch AI-powered antibody research at New XSeed Labs in Paris-Saclay
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
While overall survival data remain immature, the results pointed to a favourable trend.
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
Subscribe To Our Newsletter & Stay Updated